#Open journalism No news is bad news

Your contributions will help us continue to deliver the stories that are important to you

Support The Journal
Dublin: 8°C Saturday 15 May 2021
Advertisement

Pfizer and BioNTech ask EU to clear Covid-19 vaccine for 12 to 15-year-olds

The companies said their submission to the EMA was based on a study in more than 2,000 adolescents.

Image: Victoria Jones via PA Images

PFIZER AND BIONTECH have submitted a request for European Union drug regulators to extend the approval of the companies’ coronavirus vaccine to include children aged 12 to 15.

In a statement today, the two companies said their submission to the European Medicines Agency (EMA) was based on an advanced study in more than 2,000 adolescents that showed the vaccine to be safe and effective.

The children will continue to be monitored for longer-term protection and safety for another two years.

The move could offer younger and less at-risk populations in Europe access to the jabs for the first time.

BioNTech and Pfizer had previously requested their emergency use authorisation with the US Food and Drug Administration to be extended to children aged 12-15.

The Covid-19 vaccine made by Pfizer and BioNTech was the first to be approved by the EMA in December, when it was licensed for anyone aged 16 and over across the 27-nation EU.

#Open journalism No news is bad news Support The Journal

Your contributions will help us continue to deliver the stories that are important to you

Support us now

About the author:

Press Association

Read next:

COMMENTS (24)

This is YOUR comments community. Stay civil, stay constructive, stay on topic. Please familiarise yourself with our comments policy here before taking part.
write a comment

    Leave a commentcancel